What is the current XPH ATM implied volatility?

As of May 15, 2026, State Street SPDR S&P Pharmaceuticals ETF (XPH) at-the-money implied volatility is 23.6%. IV rank is 44.6% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.

Is XPH IV high or low historically?

IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.

What does XPH volatility skew tell options traders?

Volatility skew is the pattern by which IV varies across strikes for a given expiration. State Street SPDR S&P Pharmaceuticals ETF skew is roughly flat across the 25-delta wings. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.

State Street SPDR S&P Pharmaceuticals ETF (XPH) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

State Street SPDR S&P Pharmaceuticals ETF (XPH) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $238.3M, listed on AMEX, carrying a beta of 0.85 to the broader market. The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing public since 2006-06-22.

Snapshot as of May 15, 2026.

Spot Price: $56.92
ATM IV: 23.6%
IV Skew 25Δ: -0.019
IV Rank: 44.6%
IV Percentile: 71.4%
Term Structure Slope: 0.003

As of May 15, 2026, State Street SPDR S&P Pharmaceuticals ETF (XPH) at-the-money implied volatility is 23.6%. IV rank is 44.6% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 71.4%. The 25-delta skew is -0.019: skew is roughly flat across the 25-delta wings. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.

XPH Strategy Selection at Current Volatility Levels

For State Street SPDR S&P Pharmaceuticals ETF options at 23.6% ATM IV, mid-range IV rank (44.6%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.

Learn how volatility skew is reported and how to read the data →

Frequently asked XPH volatility skew questions

What is the current XPH ATM implied volatility?: As of May 15, 2026, State Street SPDR S&P Pharmaceuticals ETF (XPH) at-the-money implied volatility is 23.6%. IV rank is 44.6% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
Is XPH IV high or low historically?: IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
What does XPH volatility skew tell options traders?: Volatility skew is the pattern by which IV varies across strikes for a given expiration. State Street SPDR S&P Pharmaceuticals ETF skew is roughly flat across the 25-delta wings. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.